Literature DB >> 26633786

Lyme Neuroborreliosis.

Adriana R Marques.   

Abstract

PURPOSE OF REVIEW: Lyme disease, caused by the spirochete Borrelia burgdorferi, is the most common tick-borne illness in the United States and Europe. Lyme disease usually begins with the characteristic skin lesion, erythema migrans, at the site of the tick bite. Following hematogenous dissemination, neurologic, cardiac, and/or rheumatologic involvement may occur. Neurologic involvement occurs in up to 15% of untreated B. burgdorferi infection and neurologists should be familiar with its diagnosis and management. RECENT
FINDINGS: The most common early neurologic manifestations of Lyme disease are cranial neuropathy (particularly facial palsy), lymphocytic meningitis, and radiculoneuritis, which often occur in combination. Late neuroborreliosis occurs much less frequently than early disease. A combination of clinical and laboratory findings is recommended for the diagnosis of Lyme neuroborreliosis. Treatment with recommended antibiotic regimens is effective in Lyme neuroborreliosis, and patients with early disease usually have excellent outcomes. Recovery is slower and may be incomplete in patients with late disease.
SUMMARY: Nervous system involvement occurs in up to 15% of patients with untreated B. burgdorferi infection. This article reviews clinical aspects of the diagnosis and treatment of Lyme neuroborreliosis, with focus on the United States.

Entities:  

Mesh:

Year:  2015        PMID: 26633786     DOI: 10.1212/CON.0000000000000252

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  12 in total

1.  Meningoencephalitis with microinfarcts in early neuroborreliosis.

Authors:  Anne-Catherine Myriam Liliane Huys; Patrice H Lalive; Sven Haller
Journal:  Neuroradiology       Date:  2016-02-09       Impact factor: 2.804

Review 2.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

3.  Cranial neuropathy and severe pain due to early disseminated Borrelia burgdorferi infection.

Authors:  Derek Ebner; Kelsey Smith; Daniel DeSimone; Muhammad Rizwan Sohail
Journal:  BMJ Case Rep       Date:  2018-01-23

Review 4.  Challenges in the Diagnosis and Treatment of Lyme Disease.

Authors:  Robert T Schoen
Journal:  Curr Rheumatol Rep       Date:  2020-01-07       Impact factor: 4.592

Review 5.  Clinical spectrum of Lyme disease.

Authors:  Jesus Alberto Cardenas-de la Garza; Estephania De la Cruz-Valadez; Jorge Ocampo-Candiani; Oliverio Welsh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-11-19       Impact factor: 3.267

6.  Diplopia: A Rare Manifestation of Neuroborreliosis.

Authors:  Ayushi Dixit; Yesika Garcia; Lauren Tesoriero; Charles Berman; Vincent Rizzo
Journal:  Case Rep Neurol Med       Date:  2018-07-09

Review 7.  Spirochetal Lipoproteins and Immune Evasion.

Authors:  Alexei Christodoulides; Ani Boyadjian; Theodoros Kelesidis
Journal:  Front Immunol       Date:  2017-03-29       Impact factor: 7.561

8.  Prevalence of serological response to Borrelia burgdorferi in farmers from eastern and central Poland.

Authors:  V Zając; J Pinkas; A Wójcik-Fatla; J Dutkiewicz; A Owoc; I Bojar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-31       Impact factor: 3.267

9.  NF‑κB is a key modulator in the signaling pathway of Borrelia burgdorferi BmpA‑induced inflammatory chemokines in murine microglia BV2 cells.

Authors:  Zhenyu Zhao; Lvyan Tao; Aihua Liu; Mingbiao Ma; Haiyi Li; Hua Zhao; Jiaru Yang; Shiming Wang; Yirong Jin; Xian Shao; Fukai Bao
Journal:  Mol Med Rep       Date:  2018-01-31       Impact factor: 2.952

10.  A Rare Cause of Optic Neuropathy.

Authors:  Isabel O Cruz; Sara Alves Pereira; Bruna Vieira; Inês Chora; Paulo Coelho
Journal:  Cureus       Date:  2020-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.